Stay informed with today’s essential health care update, spotlighting the latest FDA gene therapy alert, urgent developments in Texas flood recovery, and actionable clinical tips for providers. From national safety pauses to local policy shifts and global health monitoring, this daily briefing keeps you aligned with what matters most—timely, evidence-based, and community-focused health news.
🇺🇸 National Updates
✅ FDA Continues to Scrutinize Gene Therapy After Safety Pause
Sarepta has paused U.S. shipments of its Duchenne muscular dystrophy gene therapy Elevidys, following FDA concerns and at least three patient deaths due to liver failure. Providers should monitor ongoing safety updates and counsel affected families.
🏥 Texas Updates
✅ Texas Mothers Protest Fed Cuts to Weather & Emergency Agencies
On July 21, grieving mothers of the 27 children lost at Camp Mystic led a protest near the White House, demanding restoration of NOAA, FEMA, and NWS funding to prevent future flood tragedies.
✅ Kerr County Moves Toward Tax Hike to Fund Flood Recovery
Following the July 4–7 floods that killed 135 people and destroyed over 2,000 buildings, Kerr County is considering a property tax increase (up to 8%) to support long-term recovery—though residents have voiced opposition.
🌍 Global Health Alerts
✅ (No new global outbreak updates today—continue routine surveillance and travel screening.)
💡 Clinical Tips for Providers
- Inform Duchenne-affected families about the Elevidys pause and recommend liver monitoring.
- Offer mental health support to Texas flood survivors and guide them toward recovery resources.
- Stay updated on Kerr County recovery plans; understand possible impacts on patient housing and access.
